NCT02925247View on ClinicalTrials.gov

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 27, 2016

Primary Completion Date

November 19, 2018

Study Completion Date

November 18, 2022

Conditions

Atrial Fibrillation

Interventions

BEHAVIORAL

Adherence to oral anticoagulant treatment

The adherence will be evaluated by biological results

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02925247 - Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients | Biotech Hunter | Biotech Hunter